Nutex Health (NUTX) Debt to Equity (2015 - 2026)

Nutex Health has disclosed Debt to Equity across 12 years of filings, most recently posting $0.09 for Q1 2026.

• Debt to Equity for Q1 2026 came in at $0.09, down 33.08% year-over-year; the trailing twelve-month figure through Mar 2026 was $0.09 (down 33.08% YoY), and the FY2025 annual result was $0.1, down 48.65% from the prior year.
• Debt to Equity came in at $0.09 for Q1 2026 at Nutex Health, down from $0.1 in the prior quarter.
• In the past five years, Debt to Equity ranged from a high of $0.47 in Q4 2023 to a low of $0.02 in Q1 2022.
• The 5-year median for Debt to Equity is $0.22 (2023), against an average of $0.23.
• Across the five-year window, Debt to Equity surged 3886.2% in 2022 and sank 81.37% in 2025, its largest moves.
• Nutex Health's Debt to Equity stood at $0.3 in 2022, then soared by 58.63% to $0.47 in 2023, then slumped by 58.34% to $0.2 in 2024, then plunged by 48.65% to $0.1 in 2025, then dropped by 7.64% to $0.09 in 2026.
• The last three Debt to Equity figures came in at $0.09 (Q1 2026), $0.1 (Q4 2025), and $0.07 (Q3 2025), per Business Quant data.